These findings not only underscore the pivotal role of CD8+ TSCM cells in depression pathophysiology but also pave the way for personalized treatment approaches aimed at restoring metabolic balance in the gut-brain axis. The gene discussed is CD8A; the disease is depressive symptom measurement.